Extended interval dosing of ocrelizumab modifies the repopulation of B cells without altering the clinical efficacy in multiple sclerosis
延长奥瑞珠单抗给药间隔可改变B细胞的再生,但不影响多发性硬化症的临床疗效
期刊:Journal of Neuroinflammation
影响因子:10.1
doi:10.1186/s12974-023-02900-z
Rodriguez-Mogeda, Carla; van Lierop, Zoë Y G J; van der Pol, Susanne M A; Coenen, Loet; Hogenboom, Laura; Kamermans, Alwin; Rodriguez, Ernesto; van Horssen, Jack; van Kempen, Zoé L E; Uitdehaag, Bernard M J; Teunissen, Charlotte E; Witte, Maarten E; Killestein, Joep; de Vries, Helga E